AI assistant
10x Genomics, Inc. — Director's Dealing 2021
Nov 4, 2021
31830_dirs_2021-11-03_65486582-9faf-419c-a26a-f6a79f4784a6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2021-11-01
Reporting Person: STUELPNAGEL JOHN R (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-11-01 | Class A Common Stock | S | 100 | $160.33 | Disposed | 361516 | Direct |
| 2021-11-01 | Class A Common Stock | S | 100 | $160.75 | Disposed | 361416 | Direct |
| 2021-11-01 | Class A Common Stock | S | 100 | $161.52 | Disposed | 361316 | Direct |
| 2021-11-01 | Class A Common Stock | S | 1494 | $163.0985 | Disposed | 359822 | Direct |
| 2021-11-01 | Class A Common Stock | S | 2906 | $163.8899 | Disposed | 356916 | Direct |
| 2021-11-01 | Class A Common Stock | S | 300 | $164.5800 | Disposed | 356616 | Direct |
Footnotes
F1: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
F2: This transaction was executed in multiple trades at prices ranging from $162.50 to $163.48. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3: This transaction was executed in multiple trades at prices ranging from $163.50 to $164.45. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F4: This transaction was executed in multiple trades at prices ranging from $164.55 to $164.63. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.